Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose

Biomaterials

Volumn 32, Issue 11, 2011, Pages 3134-3140

  Lee, Kwang ^a   Lee, Chang Yoel ^a   Jung, Hyungil ^a  

^a Yonsei University   (South Korea)

Author keywords

Controlled drawing lithography; Cutaneous depigmentation; Dissolving microneedle; Transdermal drug delivery

Indexed keywords

ASCORBIC ACIDS; CLINICAL APPLICATION; CONTROLLED DRAWING LITHOGRAPHY; CUTANEOUS DEPIGMENTATION; DISSOLVING MICRONEEDLE; ENCAPSULATED DRUGS; HYDROPHILIC MOLECULES; IN-VIVO; MICRO-SCALES; MICROCASTING; MICRONEEDLES; MINIMALLY INVASIVE; MOLDING PROCESS; NIACINAMIDE; THREE-DIMENSIONAL POLYMER STRUCTURES; TRANSCUTANEOUS; TRANSDERMAL DELIVERY; TRANSDERMAL DRUG DELIVERY; TRANSDERMAL DRUGS;

BIOPOLYMERS; CONTROLLED DRUG DELIVERY; KETONES; MALTOSE; NEEDLES; ORGANIC ACIDS; THREE DIMENSIONAL;

DISSOLUTION;

ASCORBIC ACID; ASCORBIC ACID 2 GLUCOSIDE; GLUCOSIDE; MALTOSE; NICOTINAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GUINEA PIG; HYDROPHILICITY; HYPERPIGMENTATION; MICRONEEDLE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; VISCOSITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; GUINEA PIGS; HYPERPIGMENTATION; MALTOSE; NEEDLES;

EID: 79951577061     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.01.014     Document Type: Article

References (30)

1. Prausnitz M.R., Mitragotri S., Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 2004, 3:115-124.
2. Wermeling D.P., Banks S.L., Hudson D.A., Gill H.S., Gupta J., Prausnitz M.R., et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A 2008, 105:2058-2063.
3. Mcallister D.V., Wang P.M., Davis S.P., Park J.H., Canatella P.J., Allen M.G., et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA 2003, 100:13755-13760.
4. Arora A., Prausnitz M.R., Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008, 364:227-236.
5. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004, 56:581-587.
6. Gill H.S., Prausnitz M.R. Coated microneedles for transdermal delivery. J Control Release 2007, 117:227-237.
7. Miyano T., Tobinaga Y., Kanno T., Matsuzaki Y., Takeda H., Wakui M., et al. Sugar micro needles as transdermic drug delivery system. Biomed Microdevices 2005, 7:185-188.
8. Park J.H., Allen M.G., Prausnitz M.R. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 2005, 104:51-66.
9. Lee J.W., Park J.H., Prausnitz M.R. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008, 29:2113-2124.
10. Sullivan S.P., Murthy N., Prausnitz M.R. Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater 2008, 20:933-938.
11. Park J.H., Yoon Y.K., Choi S.O., Prausnitz M.R., Allen M.G. Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery. IEEE Trans Biomed Eng 2007, 54:903-913.
12. Park J.H., Allen M.G., Prausnitz M.R. Polymer microneedles for controlled-release drug delivery. Pharm Res 2006, 23:1008-1019.
13. Park J.H., Choi S.O., Kamath R., Yoon Y.K., Allen M.G., Prausnitz M.R. Polymer particle-based micromolding to fabricate novel microstructures. Biomed Microdevices 2007, 9:223-234.
14. Ito Y., Hagiwara E., Saeki A., Sugioka N., Takada K. Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 2006, 29:82-88.
15. Kim B.J., Kim H.J., Jung S.M., Sung J.K., Lee H.H. Fabrication of microneedle using laser writtern PDMS mold for molecule trasnport into plant skin. BioChip J 2009, 3:281-286.
16. Lee K., Lee H.C., Lee D.S., Jung H. Drawing lithography: three-dimensional fabrication of an ultrahigh-aspect-ratio microneedle. Adv Mater 2010, 22:483-486.
17. Parker R., Ring S.G. Diffusion in maltose-water mixtures at temperatures close to the glass transition. Carbohydr Res 1995, 273:147-155.
18. Townrow S., Kilburn D., Alam A., Ubbink J. Molecular packing in amorphous carbohydrate matrixes. J Phys Chem B 2007, 111:12643-12648.
19. Kiverin M.D. Maltase in the skin. Biokhimiia 1957, 22:617-621.
20. Tromp R.H., Dusschoten D.V., Parker R., Ring S.G. Carbon-13 nuclear magnetic relaxation in supercooled liquid and glassy maltose. Phys Chem Chem Phys 1999, 1:1927-1931.
21. Imokawa G., Kawai M., Mishima Y., Motegi I. Differential analysis of experimental hypermelanosis induced by UVB, PUVA, and allergic contact dermatitis using a brownish guinea pig model. Arch Dermatol Res 1986, 278:352-362.
22. Finnin B.C., Morgan T.M. Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci 1999, 88:955-958.
23. Smith W.P. The effects of topical L(+) lactic acid and ascorbic acid on skin whitening. Int J Cosmet Sci 1999, 21:33-40.
24. Hakozaki T., Minwalla L., Zhuang J., Chhoa M., Matsubara A., Miyamoto K., et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002, 147:20-31.
25. Briganti S., Camera E., Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 2003, 16:101-110.
26. Parvez S., Kang M., Chung H.S., Cho C., Hong M.C., Shin M.K., et al. Survey and mechanism of skin depigmenting and lightening agents. Phytother Res 2006, 20:921-934.
27. Picardo M., Carrera M. New and experimental treatments of cloasma and other hypermelanoses. Dermatol Clin 2007, 25:353-362.
28. Stanojevic M., Stanojevic Z., Jovanovic D., Stojiljkovic M. Ultraviolet radiation and melanogenesis. Arch Oncol 2004, 12:203-205.
29. Schwartz R.A. Cutaneous metastatic disease. J Am Acad Dermatol 1995, 33:161-182.
30. Brown M.B., Martin G.P., Jones S.A., Akomeah F.K. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 2006, 13:175-187.